845306-08-3

Basic information

• Product Name: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98
• Synonyms: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98;5-Bromo-pyridine-2-carboxylic acid tert-butyl ester;tert-Butyl 5-bromopyridine-2-carboxylate 98%;5-Bromopyridine-2-carboxylic acid t-butyl ester;tert-butyl 5-bromopicolinate;2-Pyridinecarboxylic acid, 5-broMo-, 1,1-diMethylethyl ester;5-Bromo-2-pyridinecarboxylic acid 1,1-dimethylethyl ester;5-Bromopicolinic acid tert-butyl ester
• CAS NO: 845306-08-3
• Molecular Formula: C₁₀H₁₂BrNO₂
• Molecular Weight: 258.1138
• Product Categories: blocks;Bromides;Carboxes;Pyridines
• Mol File: 845306-08-3.mol
• Article Data: 7

Chemical Properties

• Melting Point: 92-94
• Boiling Point: 318℃
• Flash Point: 146℃
• Appearance: /
• Density: 1.385
• Vapor Pressure: 0.00038mmHg at 25°C
• Refractive Index: 1.531
• Storage Temp.: Keep Cold
• PKA: -0.52±0.10(Predicted)
• CAS DataBase Reference: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98(845306-08-3)
• EPA Substance Registry System: TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98(845306-08-3)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 845306-08-3(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98 is a chemical compound commonly used in the pharmaceutical industry for the synthesis of various drugs and pharmaceuticals. It is a tert-butyl ester derivative of 5-bromopyridine-2-carboxylic acid with a high purity of 98%. TERT-BUTYL 5-BROMOPYRIDINE-2-CARBOXYLATE 98 is a versatile building block in organic synthesis, particularly in the development of new drugs and chemical compounds. Its high level of purity makes it ideal for use in research and development, as well as in the production of pharmaceuticals.

InChI:InChI=1/C10H12BrNO2/c1-10(2,3)14-9(13)8-5-4-7(11)6-12-8/h4-6H,1-3H3

Upstream product

• 30766-11-1 5-bromoisonicotinic acid 
• 75-65-0 tert-butyl alcohol 
• 29682-15-3 methyl 5-bromopicolinate 
• 36805-97-7 N,N-dimethylformamide di-tert-butyl acetal 

Downstream Products

• 30766-11-1 5-bromoisonicotinic acid 
• 1300728-31-7 tert-butyl 5-[(2-chlorophenyl)amino]picolinate 
• 1354356-24-3 tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate 
• 1354355-67-1 tert-butyl 5-(3-fluorophenyl)picolinate 
• 1158763-55-3 5-(3-fluorophenyl)picolinic acid 
• 1354353-83-5 N-((2'-fluoro-3-methyl-2,4'-bipyridin-5-yl)methyl)-5-(3-fluorophenyl)picolinamide 
• 1354353-90-4 5-(3-fluorophenyl)-N-((2'-(trifluoromethyl)-2,4'-bipyridin-S-yl)methyl)picolinamide 
• 1214339-84-0 3,3'-bipyridine-6-carboxylic acid 
• 1403333-23-2 (S)-N-(1-(3-(3-Chloro-4-cyano-5-fluorophenyl)-1H-pyrazol-1-yl)propan-2-yl)-3,3'-bipyridine-6-carboxamide 
• 1300728-36-2 tert-butyl 5H-pyrido[3,2-b]indole-2-carboxylate 
• 93835-05-3 3-tert-butoxycarbonyl-β-carboline 

Relevant articles and documents

BENZAMIDE CGRP RECEPTOR ANTAGONISTS

The present invention is directed to benzamide compounds which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.

ANDROGEN RECEPTOR MODULATING CARBOXAMIDES

Compounds of formula (I) wherein Rx, Rz, R9, R10, R14, R14', R15, R15', A and B are as defined in the claims and pharmaceutically acceptable salts and esters thereof, are disclosed. The compounds possess utility as tissue-selective androgen receptor modulators (SARM) and are particularly useful as medicaments in the treatment of prostate cancer and other AR dependent conditions and diseases where AR antagonism is desired.

METHYLENE DIPIPERIDINE DERIVATIVES

The present invention relates to novel methylene dipiperidine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.